DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
M•••• • A•••••••
Healthcare & Pharmaceuticalsgroup grade Aon a schedule nowsponsor unattributed
Principal held
at least $4.0M
sum of BDC pieces, a lower bound
Fair value
$4.4M
102c on cost, debt pieces
Unfunded
n/a
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
2
1 equity pieces beside them
Next maturity
May 3, 2029
no dated debt inside 24 months
On the tape since
Jun 30, 2023
latest Jun 30, 2026
Events
5
dated, non-routine
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien | at least $4.0M | 101c | SOFR+500 bp | May 3, 2029 | 1 |
| first lien revolver first lien | at least $0 | n/a | SOFR+525 bp | May 3, 2029 | 1 |
Equity pieces beside the debt: equity ($410,949 fair value, 1 BDC)
Lenders
every BDC piece at the latest quarter end
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| A•••• C••••• B•• I••• | revolver first lien Investment T••• 1st L••• R••••••• I•••• S+ S••••• 5.25% I••••••• R••• 8.98% A••••••••• D•• | $0 | $0 0c | SOFR+525 bp |
| A•••• C••••• B•• I••• | term loan first lien Investment T••• U••••••••• T••• L••• I•••• S+ S••••• 5.00% I••••••• R••• 8.73% A••••••••• | $4.0M | $4.0M 101c | SOFR+500 bp |
| A•••• C••••• B•• I••• | revolver first lien Investment T••• S••••• S•••••• R•••••••• L••• (F•••• L•••) I•••• S+ S••••• 5.00% I••••••• | n/a | n/a | SOFR+525 bp |
| A•••• C••••• B•• I••• | equity equity Investment T••• C•••• A U•••• A••••••••• D••• 5/3/2023 | n/a | $410,949 189c |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2026 | 1 | $4.0M | $4.0M | 102c | 0 |
| Mar 31, 2026 | 1 | $4.0M | $4.0M | 102c | 0 |
| Dec 31, 2025 | 1 | $4.0M | $4.0M | 102c | 0 |
| Sep 30, 2025 | 1 | $4.0M | $4.0M | 102c | 0 |
| Jun 30, 2025 | 1 | $4.0M | $4.0M | 102c | 0 |
| Mar 31, 2025 | 1 | $4.0M | $4.0M | 103c | 0 |
| Dec 31, 2024 | 1 | $8.3M | $8.3M | 103c | 0 |
| Sep 30, 2024 | 1 | $4.0M | $4.0M | 103c | 0 |
| Jun 30, 2024 | 1 | $4.1M | $4.1M | 103c | 0 |
| Mar 31, 2024 | 1 | $4.1M | $4.1M | 103c | 0 |
| Dec 31, 2023 | 1 | $12.2M | $12.2M | 103c | 0 |
| Sep 30, 2023 | 1 | $4.1M | $4.0M | 101c | 0 |
| Jun 30, 2023 | 1 | $4.1M | $4.0M | 100c | 0 |
What changed
- Spread changed (observed)Dec 31, 2024
- Spread changed (observed)Dec 31, 2024
- Spread changed (observed)Jun 30, 2024
- Spread changed (observed)Jun 30, 2024
- New borrower on a BDC scheduleJun 30, 2023
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- MINDS ASSEMBLYderivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 1 BDCderived
- Industry
- Healthcare & Pharmaceuticalsreportedas one filer wrote it